Vectura Group’s (VEC) “Hold” Rating Reiterated at Peel Hunt

Share on StockTwits

Vectura Group (LON:VEC)‘s stock had its “hold” rating reaffirmed by equities researchers at Peel Hunt in a research note issued to investors on Tuesday.

Several other equities research analysts have also commented on VEC. JPMorgan Chase & Co. reiterated an “overweight” rating and set a GBX 140 ($1.86) price objective on shares of Vectura Group in a research note on Tuesday, March 13th. N+1 Singer reiterated a “buy” rating and set a GBX 120 ($1.60) price objective on shares of Vectura Group in a research note on Wednesday, March 21st. Shore Capital reiterated a “hold” rating on shares of Vectura Group in a research note on Monday, March 12th. Numis Securities reiterated a “buy” rating and set a GBX 170 ($2.26) price objective on shares of Vectura Group in a research note on Monday, March 12th. Finally, Stifel Nicolaus reiterated a “buy” rating and set a GBX 151 ($2.01) price objective on shares of Vectura Group in a research note on Thursday, March 22nd. Three investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of GBX 134.56 ($1.79).

LON VEC opened at GBX 79 ($1.05) on Tuesday. Vectura Group has a twelve month low of GBX 70 ($0.93) and a twelve month high of GBX 166.97 ($2.22).

Vectura Group Company Profile

Vectura Group plc researches, develops, and commercializes novel therapeutic products and drug delivery systems for the treatment of airways-related diseases. The company's marketed products include Ultibro Breezhaler and Seebri Breezhaler for the treatment of chronic obstructive pulmonary disease (COPD); AirFlusal Forspiro for the treatment of asthma and COPD; ADVATE for the treatment of haemophilia A; and Adept for the treatment of surgical adhesions.

Analyst Recommendations for Vectura Group (LON:VEC)

Receive News & Ratings for Vectura Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vectura Group and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Bristol-Myers Squibb’s  Hold Rating Reaffirmed at BMO Capital Markets
Bristol-Myers Squibb’s Hold Rating Reaffirmed at BMO Capital Markets
Home Depot Inc  Given Consensus Recommendation of “Buy” by Analysts
Home Depot Inc Given Consensus Recommendation of “Buy” by Analysts
Korn/Ferry International  Receives $61.80 Average Price Target from Brokerages
Korn/Ferry International Receives $61.80 Average Price Target from Brokerages
Agrello Market Capitalization Hits $7.40 Million
Agrello Market Capitalization Hits $7.40 Million
Dreamcoin Hits Market Capitalization of $93,767.00
Dreamcoin Hits Market Capitalization of $93,767.00
Superior Group of Companies  Receiving Somewhat Positive Media Coverage, Analysis Finds
Superior Group of Companies Receiving Somewhat Positive Media Coverage, Analysis Finds


© 2006-2018 Ticker Report. Google+.